Development of a relationship counselling website to identify and mitigate risk of intimate partner violence in the context of women's PrEP use.


Journal

PLOS digital health
ISSN: 2767-3170
Titre abrégé: PLOS Digit Health
Pays: United States
ID NLM: 9918335064206676

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 22 08 2022
accepted: 18 07 2023
medline: 14 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Discreet, accessible interventions are urgently needed to mitigate the risk of intimate-partner violence (IPV) and other relationship barriers that women encounter to using HIV prevention methods such as pre-exposure prophylaxis (PrEP). We adapted a counsellor-administered intervention, CHARISMA, into a mobile-optimized website to enhance accessibility and reduce human resources required for HIV prevention and relationship counseling. Using human-centered design and participatory methods, CHARISMA was adapted through workshops with former CHARISMA in-person intervention participants (n = 14; ages 18-45) and web development 'sprints' combined with cognitive interviews (n = 24). 'CHARISMA mobile' was then beta-tested with 81 women naïve to the in-person intervention. In beta-testing, participants used a 'think aloud' process to provide feedback on ease of use and rated design, functionality, comprehension, confidentiality, safety, and usefulness on a scale of 1 to 5 via a survey. Data were conducted in four rounds, interspersed with rapid assessment according to go/no-go criteria, and website adaptations. The updated website was pilot tested for 'real-world' feasibility and acceptability among 159 women using their own smartphones at a location of their choice. Feedback was measured via surveys and website analytics. Workshops and cognitive interviews generated insights on technology use, contextual adaptations, and confidentiality, which were integrated into the beta version. The beta version met all 'go' criteria and was further adapted for pilot testing. In pilot testing, users found the website was useful (mean rating 4.54 out of 5), safe (4.5 out of 5), and had few concerns about confidentiality (1.75, representing low concern). On average, users rated the website more than 4 stars out of 5. Beta and pilot-testing suggested the smartphone-optimized website was well-accepted, relevant, engaging, feasible to administer, discreet and safe. Results contributed to a refined website, suitable for adaptations to other contexts and further evaluation where outcomes related to PrEP use and relationships should be assessed.

Identifiants

pubmed: 37578954
doi: 10.1371/journal.pdig.0000329
pii: PDIG-D-22-00248
pmc: PMC10424861
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000329

Informations de copyright

Copyright: © 2023 Hartmann et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Med Internet Res. 2016 Dec 16;18(12):e317
pubmed: 27986647
J Int AIDS Soc. 2014 Sep 08;17(3 Suppl 2):19159
pubmed: 25224618
PLoS One. 2022 Jan 21;17(1):e0261973
pubmed: 35061757
BMC Public Health. 2020 Jun 26;20(1):1016
pubmed: 32590969
Front Psychiatry. 2019 Nov 13;10:759
pubmed: 31798468
J Interpers Violence. 2022 Jul;37(13-14):NP11436-NP11459
pubmed: 33576291
Harv Bus Rev. 2003 Dec;81(12):46-54, 124
pubmed: 14712543
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32675229
Stud Fam Plann. 2017 Jun;48(2):179-200
pubmed: 28422291
PLoS One. 2021 Dec 31;16(12):e0261526
pubmed: 34972141
PLoS One. 2020 Dec 22;15(12):e0242881
pubmed: 33351805
BMC Infect Dis. 2018 Nov 16;18(1):581
pubmed: 30445925
J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):386-393
pubmed: 30570528
PLoS One. 2015 Feb 18;10(2):e0118234
pubmed: 25693056
Health Promot Pract. 2020 Jan;21(1):37-48
pubmed: 31131633
AIDS Educ Prev. 2021 Apr;33(2):103-119
pubmed: 33821679
J Med Internet Res. 2017 Jun 29;19(6):e232
pubmed: 28663162
Front Digit Health. 2022 Apr 25;4:848052
pubmed: 35547091
AIDS Behav. 2018 Apr;22(4):1190-1200
pubmed: 28887703
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):580-589
pubmed: 30239426
Int J STD AIDS. 2021 Mar;32(3):228-238
pubmed: 33555232
J Acquir Immune Defic Syndr. 2022 Aug 1;90(4):425-433
pubmed: 35416797
BMC Public Health. 2019 Jul 8;19(1):897
pubmed: 31286914
PLoS One. 2017 Aug 24;12(8):e0180699
pubmed: 28837562
Campbell Syst Rev. 2022 Aug 27;18(3):e1271
pubmed: 36909881
AIDS Behav. 2021 Feb;25(2):427-437
pubmed: 32813087
AIDS Behav. 2020 Aug;24(8):2299-2306
pubmed: 31953703
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):313-322
pubmed: 27243900
Soc Sci Med. 2014 Jun;110:49-55
pubmed: 24721447
AIDS Educ Prev. 2019 Oct;31(5):433-451
pubmed: 31550193
PLoS One. 2020 Apr 30;15(4):e0228620
pubmed: 32352969
BMC Public Health. 2020 May 29;20(1):808
pubmed: 32471469
J Adolesc Health. 2012 Dec;51(6):535-43
pubmed: 23174462
PLoS One. 2020 Nov 2;15(11):e0241480
pubmed: 33137123
Int J Environ Res Public Health. 2023 Jan 13;20(2):
pubmed: 36674209
AIDS Behav. 2020 May;24(5):1432-1442
pubmed: 31667678
AIDS Care. 2019 Jun;31(6):660-666
pubmed: 30309246
BMC Public Health. 2020 Sep 15;20(1):1403
pubmed: 32933510

Auteurs

Miriam Hartmann (M)

Women's Global Health Imperative, RTI International, Berkeley, California, United States of America.
Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Sarah T Roberts (ST)

Women's Global Health Imperative, RTI International, Berkeley, California, United States of America.

Noah Triplett (N)

Women's Global Health Imperative, RTI International, Berkeley, California, United States of America.

Siyanda Tenza (S)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Onthatile Maboa (O)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Lydia Mampuru (L)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Nonkululeko Mayisela (N)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Dorica Mbewe (D)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Elizabeth E Tolley (EE)

FHI360, Durham, North Carolina, United States of America.

Krishnaveni Reddy (K)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Thesla Palanee-Phillips (T)

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
University of Washington, Department of Epidemiology; School of Public Health, Seattle, United States of America.

Elizabeth T Montgomery (ET)

Women's Global Health Imperative, RTI International, Berkeley, California, United States of America.

Classifications MeSH